======= CCL8 ======= == Gene Information == * **Official Symbol**: CCL8 * **Official Name**: C-C motif chemokine ligand 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6355|6355]] * **UniProt**: [[https://www.uniprot.org/uniprot/P80075|P80075]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CCL8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CCL8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602283|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils. May play a role in neoplasia and inflammatory host responses. This protein can bind heparin. The processed form MCP-2(6-76) does not show monocyte chemotactic activity, but inhibits the chemotactic effect most predominantly of CCL7, and also of CCL2 and CCL5 and CCL8. {ECO:0000269|PubMed:9558113}. |IL8| |negative regulation by host of viral genome replication| |phospholipase activator activity| |negative regulation by host of viral process| |modulation by host of viral genome replication| |eosinophil chemotaxis| |eosinophil migration| |modulation by host of viral process| |CCR chemokine receptor binding| |monocyte chemotaxis| |lymphocyte chemotaxis| |mononuclear cell migration| |chemokine activity| |negative regulation of viral genome replication| |lymphocyte migration| |modification by host of symbiont morphology or physiology| |interaction with symbiont| |negative regulation of leukocyte proliferation| |chemokine-mediated signaling pathway| |cell| |negative regulation of viral life cycle| |neutrophil chemotaxis| |granulocyte chemotaxis| |response to chemokine| |cellular response to chemokine| |neutrophil migration| |regulation of viral genome replication| |negative regulation of viral process| |granulocyte migration| |modification of morphology or physiology of other organism involved in symbiotic interaction| |myeloid leukocyte migration| |positive regulation of leukocyte migration| |leukocyte chemotaxis| |regulation of viral life cycle| |modification of morphology or physiology of other organism| |cellular response to interferon-gamma| |heparin binding| |cellular response to interleukin-1| |response to interferon-gamma| |regulation of leukocyte migration| |response to interleukin-1| |regulation of viral process| |cell chemotaxis| |positive regulation of ERK1 and ERK2 cascade| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |regulation of leukocyte proliferation| |protein kinase activity| |cellular response to tumor necrosis factor| |calcium ion transport| |response to tumor necrosis factor| |response to virus| |regulation of ERK1 and ERK2 cascade| |divalent metal ion transport| |divalent inorganic cation transport| |leukocyte migration| |positive regulation of GTPase activity| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |regulation of GTPase activity| |divalent inorganic cation homeostasis| |inflammatory response| |positive regulation of cell migration| |positive regulation of cell motility| |positive regulation of cellular component movement| |positive regulation of MAPK cascade| |chemotaxis| |taxis| |positive regulation of locomotion| |cellular metal ion homeostasis| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |cytokine-mediated signaling pathway| |negative regulation of cell population proliferation| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |regulation of MAPK cascade| |innate immune response| |positive regulation of hydrolase activity| |regulation of multi-organism process| |symbiotic process| |ion homeostasis| |exocytosis| |interspecies interaction between organisms| |cation transport| |regulation of cell migration| |cellular homeostasis| |regulation of cell motility| |defense response to other organism| |cell migration| |protein phosphorylation| |regulation of locomotion| |regulation of cellular component movement| |secretion by cell| |cellular response to cytokine stimulus| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |export from cell| |positive regulation of phosphorylation| |cell motility| |localization of cell| |response to cytokine| |chemical homeostasis| |cell-cell signaling| |secretion| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of immune system process| |positive regulation of protein modification process| |regulation of hydrolase activity| |phosphorylation| |response to other organism| |response to external biotic stimulus| |locomotion| |G protein-coupled receptor signaling pathway| |response to biotic stimulus| |defense response| |ion transport| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |movement of cell or subcellular component| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |homeostatic process| |regulation of immune system process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |immune response| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.85| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.7| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.72| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.83| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|2.19| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18676 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}